BioLineRx, Innovative Pharmaceutical Concepts Ltd. deal

Innovative granted BLRX exclusive, worldwide rights to develop and commercialize BL-5010 for non-surgical removal of skin lesions. The topical combination of organic acids is in preclinical testing. ...